![Aggressive treatment for some stage IV lung cancer patients can dramatically improve overall survival - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO) Aggressive treatment for some stage IV lung cancer patients can dramatically improve overall survival - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO)](https://www.astro.org/ASTRO/media/ASTRO/News%20and%20Publications/News%20Releases/LongTermSurvival.jpg?ext=.jpg)
Aggressive treatment for some stage IV lung cancer patients can dramatically improve overall survival - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO)
![Stereotactic Body Radiation Therapy an Effective Option for Early-Stage Lung Cancer Patients - The ASCO Post Stereotactic Body Radiation Therapy an Effective Option for Early-Stage Lung Cancer Patients - The ASCO Post](https://ascopost.com/media/3765/51409_chart.jpg)
Stereotactic Body Radiation Therapy an Effective Option for Early-Stage Lung Cancer Patients - The ASCO Post
![Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial - The Lancet Oncology Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/48edbd73-5c76-4ef2-8cb0-10186ab07230/gr1.gif)
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial - The Lancet Oncology
![Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab - Radiotherapy and Oncology Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2058609989/2062081446/gr1.jpg)
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab - Radiotherapy and Oncology
![Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab - Clinical Lung Cancer Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e337cfbd-aa4c-4910-a943-68a04a9c8052/gr1_lrg.jpg)
Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab - Clinical Lung Cancer
![Changing equipoise in the landscape of radiation for oligometastatic lung cancer - Schroeder - Translational Lung Cancer Research Changing equipoise in the landscape of radiation for oligometastatic lung cancer - Schroeder - Translational Lung Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/5/articles/30715/public/30715-PB3-1930-R1.png)
Changing equipoise in the landscape of radiation for oligometastatic lung cancer - Schroeder - Translational Lung Cancer Research
![Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/6f0f6a26-4650-4185-9b00-fee9630157e6/gr1.jpg)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis | European Respiratory Society Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis | European Respiratory Society](https://erj.ersjournals.com/content/erj/53/6/1801568/F2.large.jpg)
Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis | European Respiratory Society
![Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative. - ppt download Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative. - ppt download](https://slideplayer.com/13201904/79/images/slide_1.jpg)
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative. - ppt download
![Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer - Journal of Thoracic Oncology Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2118869200/2086060581/gr1.jpg)
Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer - Journal of Thoracic Oncology
![Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients](https://www.jcancer.org/v10/p0168/jcav10p0168g001.jpg)
Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients
![Is Targeted Radiation Therapy Best for Your Early-Stage Lung Cancer? – Health Essentials from Cleveland Clinic Is Targeted Radiation Therapy Best for Your Early-Stage Lung Cancer? – Health Essentials from Cleveland Clinic](https://2rdnmg1qbg403gumla1v9i2h-wpengine.netdna-ssl.com/wp-content/uploads/sites/3/2019/01/sbrt-CCpic-770x553-650x428.jpg)
Is Targeted Radiation Therapy Best for Your Early-Stage Lung Cancer? – Health Essentials from Cleveland Clinic
![Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival - ScienceDirect Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500217303082-gr1a.jpg)
Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival - ScienceDirect
![Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial - The Lancet Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2001003156/2003739629/gr1.gif)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial - The Lancet
![Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature | Future Science OA Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature | Future Science OA](https://www.future-science.com/cms/10.2144/fsoa-2019-0120/asset/images/medium/figure1.gif)
Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature | Future Science OA
![Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection - The Journal of Thoracic and Cardiovascular Surgery Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection - The Journal of Thoracic and Cardiovascular Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/41de99d9-636a-4638-a3b6-8c8b820ceebd/gr1.jpg)
Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection - The Journal of Thoracic and Cardiovascular Surgery
![Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study - The Lancet ... Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study - The Lancet ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2117427411/2085530473/gr1.gif)
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study - The Lancet ...
![Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer - Lung Cancer Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1a586ff0-49b9-4d9b-a254-2e372b6b3cb7/gr1.jpg)
Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer - Lung Cancer
![Risk of second primary lung cancer in women after radiotherapy for breast cancer - Radiotherapy and Oncology Risk of second primary lung cancer in women after radiotherapy for breast cancer - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2023179681/2043609460/gr1.jpg)